Study offers new insights into long COVID
A new study suggests that some long COVID patients produce antibodies that attack brain and nerve tissues, indicating an autoimmune response may contribute to the condition. Researchers found these autoantibodies target areas of the nervous system linked to symptoms like brain fog and fatigue. The findings could lead to new treatments by applying therapies used for autoimmune diseases. The study highlights one possible cause of long COVID, though more research is needed to fully understand the condition.
A study found that some long COVID patients have antibodies attacking their own brain and nerve tissues, suggesting an autoimmune response may be involved.
This discovery could lead to new treatments for long COVID by using therapies already effective for autoimmune diseases.
The research provides hope for understanding and addressing the complex and varied symptoms of long COVID, helping those affected seek better care.
upbeatBytes summarizes in its own words and links to the original publisher — it doesn't host the article.